Drugs / BI 498306
last change Jun 2016 re-read 2 minutes ago

BI 498306

Developed for
schizophrenia
Investigated by
Boehringer Ingelheim

Trials 1 · a red edge is where a trial was stopped

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02281773 Nov 2014 → May 2016 schizophrenia Boehringer Ingelheim Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BI 498306 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02281773